This topic contains 0 replies, has 1 voice, and was last updated by  MS News Today Moderator 1 month, 1 week ago.

  • Author
    Posts
  • #18321
     MS News Today Moderator 
    Participant

    Ludwig Kappos, principal investigator of the EXPAND study, discusses how new analyses are answering the question of how Mayzent benefits patients. Read the full story here.

    What do you think of this study and its findings?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account